World ADC Content Library
Welcome to the World ADC media hub. Here you will find exclusive insights from our expert speakers, past presentations and articles plus much more.
Email adc@hansonwade.com if you submit for approval content that you wish to share.
ADC Magazine
Goodwin Biotechnology Poster
ADC London Post Event Report
Speaker Interview
Antibody Drug Conjugates Clinical E-Book
Abzena announces 20m$ investment
2017 Post Event Report
Past Presentations
ADCs with two bundles of chelator groups of
radionuclides for theranostic applications
Assessing Phase 1 Interim Data of
MORAb-202, a Folate Receptor
Alpha-Targeted Antibody-Drug
Conjugate
Toshimitsu Uenaka.
Linker Design: Why so complex? – GNF
Bernhard Geierstanger
Clinical Development of ADCs: ARX788, a Her2-targeting ADC as an Example – Ambrx
Yong-jiang Hei, M.D., Ph.D.
Novel Warheads for Targeted Therapies of Cancer - pro-PBDs: from Design to Clinical Candidates
Iontcho R. Vlahov, PhD
VP of Discovery Chemistry
Endocyte, Inc., West Lafayette, IN, USA
